172 related articles for article (PubMed ID: 33636496)
41. Hypertrophic cardiomyopathy: New pathogenic variant in MYH7.
Vargas-Ursúa F; Melendo-Viu M; Íñiguez-Romo A
Med Clin (Barc); 2024 Jun; 162(11):563-564. PubMed ID: 38423942
[No Abstract] [Full Text] [Related]
42. Generation of an induced pluripotent stem cell line, ICGi028-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.E510Q mutation in HADHA.
Dementyeva EV; Vyatkin YV; Chernyavsky AM; Zakian SM
Stem Cell Res; 2021 May; 53():102348. PubMed ID: 33887580
[TBL] [Abstract][Full Text] [Related]
43. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
44. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
[TBL] [Abstract][Full Text] [Related]
45. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407
[TBL] [Abstract][Full Text] [Related]
46. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
[TBL] [Abstract][Full Text] [Related]
47. End-stage Hypertrophic Cardiomyopathy with Advanced Heart Failure in Patients Carrying MYH7 R453 Variants: A Case Series.
Naito S; Higo S; Kameda S; Ogawa S; Tabata T; Akazawa Y; Nakamura D; Nakamoto K; Sera F; Kuramoto Y; Asano Y; Hikoso S; Miyagawa S; Sakata Y
Intern Med; 2023 Nov; 62(21):3167-3173. PubMed ID: 36948619
[TBL] [Abstract][Full Text] [Related]
48. Radiomic Analysis of Native T
Wang J; Yang F; Liu W; Sun J; Han Y; Li D; Gkoutos GV; Zhu Y; Chen Y
J Magn Reson Imaging; 2020 Dec; 52(6):1714-1721. PubMed ID: 32525266
[TBL] [Abstract][Full Text] [Related]
49. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
[TBL] [Abstract][Full Text] [Related]
50. Circulating miR-499a-5p Is a Potential Biomarker of
Baulina N; Pisklova M; Kiselev I; Chumakova O; Zateyshchikov D; Favorova O
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409153
[TBL] [Abstract][Full Text] [Related]
51. An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene.
Cheng D; Zhang S; Li X; Wang L; Dong J; Sang H
Stem Cell Res; 2022 Aug; 63():102848. PubMed ID: 35772297
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of genotype-phenotype correlation for a novel MYH7-D554Y mutation identified in an ethnic Han Chinese pedigree affected with hypertrophic cardiomyopathy].
Yang Q; Wang B; Wang J; Sun C; Ma Z; Zuo L; Zhang Y; Liu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):667-671. PubMed ID: 30298491
[TBL] [Abstract][Full Text] [Related]
53. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
[TBL] [Abstract][Full Text] [Related]
54. Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy.
Herrera-Rodríguez DL; Totomoch-Serra A; Rosas-Madrigal S; Luna-Limón C; Marroquín-Ramírez D; Carnevale A; Rosendo-Gutiérrez R; Villarreal-Molina MT; Márquez-Murillo MF
Arch Cardiol Mex; 2020; 90(1):58-68. PubMed ID: 31996869
[TBL] [Abstract][Full Text] [Related]
55. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
[TBL] [Abstract][Full Text] [Related]
56. Genetic variations of beta-MYH7 in Venezuelan patients with hypertrophic cardiomyopathy.
Rodríguez R; Guerrero D; Rivas Y; Lacruz A; Flores Y
Invest Clin; 2014 Mar; 55(1):23-31. PubMed ID: 24758099
[TBL] [Abstract][Full Text] [Related]
57. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.
Lan F; Lee AS; Liang P; Sanchez-Freire V; Nguyen PK; Wang L; Han L; Yen M; Wang Y; Sun N; Abilez OJ; Hu S; Ebert AD; Navarrete EG; Simmons CS; Wheeler M; Pruitt B; Lewis R; Yamaguchi Y; Ashley EA; Bers DM; Robbins RC; Longaker MT; Wu JC
Cell Stem Cell; 2013 Jan; 12(1):101-13. PubMed ID: 23290139
[TBL] [Abstract][Full Text] [Related]
58. Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants.
Manhas A; Jahng JWS; Vera CD; Shenoy SP; Knowles JW; Wu JC
Stem Cell Res; 2022 May; 61():102774. PubMed ID: 35413566
[TBL] [Abstract][Full Text] [Related]
59. A feline orthologue of the human MYH7 c.5647G>A (p.(Glu1883Lys)) variant causes hypertrophic cardiomyopathy in a Domestic Shorthair cat.
Schipper T; Van Poucke M; Sonck L; Smets P; Ducatelle R; Broeckx BJG; Peelman LJ
Eur J Hum Genet; 2019 Nov; 27(11):1724-1730. PubMed ID: 31164718
[TBL] [Abstract][Full Text] [Related]
60. MYH7 Gene-Related Mutation p.V878L Identified in a Chinese Family with Hypertrophic Cardiomyopathy.
Du Y; Wang Y; Han X; Feng Z; Ma A
Int Heart J; 2019 Nov; 60(6):1415-1420. PubMed ID: 31735781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
